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P-loop NTPase activation by allosteric effectors commonly occurs in various 
motor and signaling systems, such as actin-myosin, microtubule-kinesin, GEF-G-
protein or DNA-DNA polymerase complexes. Although its significance in eukaryotic 
cell functioning, the structural mechanism of activation is still unrevealed.  
F-actin serves as a track for myosin’s motor functions and activates its 
ATPase activity, enabling actomyosin to produce effective force against load. The rate 
limiting step of the myosin II enzyme cycle in the absence of actin is the up-to-down 
lever swing i.e. the reverse recovery step, determining the basal steady-state ATPase 
activity of myosin. Actin accelerates the reverse recovery step, thereby enabling other 
steps of the myosin enzyme cycle to become rate-limiting in the presence of actin. As 
a result, myosin’s steady-state ATPase activity increases by several orders of 
magnitude.  
Actin activation is carried out by actin binding weakly to myosin in its pre-
powerstroke state, creating the initial powerstroke state of the myosin enzyme cycle. 
During powerstroke, which is the actin-attached up-to-down lever swing, actin-
binding strengthens and phosphate is released from the actomyosin complex. Actin 
activation channels myosin heads into the effective route of the myosin enzyme cycle 
by the kinetic selection pathway mechanism, leading through the powerstroke step. 
Although actin activation is a common mechanism among myosins, its structural 
background has been unrevealed, mainly due to the limited knowledge of the 
structures of the initial, end and intermediate states of the powerstroke. Even the 
structural element of myosin specifically responsible for actin activation is 
unrevealed.  
Recently, a possible start-of-powerstroke, or intermediate powerstroke state 
of myosin has been detected in the presence of ADP and blebbistatin, which is a 
myosin II specific inhibitor. The crystallization of the myosin-ADP-blebbistatin 
complex has been hindered due to the low affinity of blebbistatin to the myosin-ADP 
complex. Therefore, the atomic structure of an important state of the powerstroke 







In order to reveal insights into the mechanism of actin activation of myosin, the 
following aims are addressed: 
• reveal the myosin structural element specifically responsible for the actin 
activation of myosin 
• examine the specific role of actin activation of myosin in vivo 
• determine the atomic structure of the initial, weak-binding actomyosin state 
of the powerstroke 
• discover communication pathways from the actin-binding region to the 
nucleotide binding pocket and converter/lever region of myosin 
• enhance the crystallization of the myosin-ADP-blebbistatin complex by 
covalent cross-linking of blebbistatin to myosin in the presence of ADP 
Theses - Results 
1. We described a novel interaction between a conserved loop of myosin and the 
N-terminal region of actin, which interaction is specifically responsible for the actin 
activation of myosin. We named this newly discovered actin-binding loop of myosin as 
activation loop. 
We conducted in silico docking of an actin trimer model and weak actin-binding up 
lever (PDB code: 1VOM), down lever (1MMD) and strong actin-binding (2OVK) 
myosin structures. Molecular dynamic relaxation of the actomyosin complexes and in 
vitro cross-linking experiments revealed a novel actin-binding loop that creates salt 
bridge interactions with the N-terminal region of actin. We characterized the steady-
state and transient kinetic properties of the actin-binding loop mutant Dictyostelium 
discoideum myosin II motor domain (Dd MD) constructs, which were similar to the 
wild type in the absence of actin. Mutations in the loop slightly affected the actin-
binding of Dd MD, whereas they almost completely abolished the actin activated 
ATPase activity of myosin, therefore we named the newly discovered actin-binding 
myosin region as activation loop. The decrease of actin activation was also observed 
in activation loop mutant Mus musculus myosin Va S1 (myoV).  
2. Actin activation and in vitro motility of myosin is decoupled upon abolishing 
the interaction between activation loop of myosin and the N-terminal region of actin. 
 Activation loop mutant Dd MD constructs incapable of being activated by actin are 




3. Actin activation of myosin’s ATPase activity enables in vivo force-generation 
of the actomyosin system. 
We created transgenic Caenorhabditis elegans (C. elegans) strains, containing wild 
type or activation loop mutant body-wall myosin. Animals bearing a mutation in their 
activation loop of body-wall myosin moved faster than the body-wall myosin 
knockout worms, although slower than the wild type animals. In contrast, force-
generation of activation loop mutant worms was completely abolished compared to 
wild type animals, and were similar to body-wall myosin knock out C. elegans. 
4. By in silico methods we determined the atomic structure of the weak-binding 
actomyosin complex representing the initial state of the powerstroke, where myosin is 
in an ‘extra primed’, novel structural state.  
We carried out in silico docking of an actin trimer and a myosin motor domain in its 
up-lever, weak actin-binding state (1VOM) and performed a 100 ns-long molecular 
dynamic relaxation of the resulted weak-binding actomyosin complex. By the same 
method, we determined structures of the strong-binding rigor actomyosin (actin trimer 
+ apo/rigor-like crystal structures, 1Q5G/2OVK), and compared the results to existing 
rigor complexes for the validation of our method. The weak-binding actomyosin 
complex relaxed to an 18⁰ further up lever accompanied with a further closed switch 
II structural state of myosin upon molecular dynamics, which represents a novel, 
‘extra primed’, initial state of the powerstroke.  
5. The interaction between activation loop of myosin and actin N-terminal 
region is responsible for the extra primed state of myosin in the initial powerstroke 
state. 
In silico mutations that abolish the interaction between activation loop and actin N-
terminal region cause the ‘back-relaxation’ of the extra primed state of myosin upon 
molecular dynamics. In silico mutations in other actin-binding loops of myosin cause 
no such effect. 
6. We revealed a weak actin-binding induced structural communication 
pathway originating from the actin-binding activation loop towards the relay region 
and nucleotide-binding pocket of myosin. 
Upon the formation of the interaction between the N-terminal region of actin and 
activation loop of myosin in the weak actomyosin complex, the upper relay region 
(where activation loop is situated) becomes interconnected with the relay helix and 
switch II loop of the nucleotide-binding pocket through salt bridge and hydrophobic 
interactions, causing the formation of the extra primed state of myosin. In silico 
mutation of activation loop abolishes this structural communication pathway between 
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the actin-binding region, lever and nucleotide-binding pocket of myosin, while other 
actin-binding loop mutations leave the interactions intact. 
 
7. We covalently saturated myosin with a photoreactive derivative of 
blebbistatin, para-azidoblebbistatin in the presence of ADP, thereby enabling the 
crystallization of the myosin-ADP-azidoblebbistatin complex. 
 
We synthesized para-azidoblebbistatin, the C15 azido-derivative of blebbistatin, 
which can be covalently cross-linked to myosin upon photo-activation by UV 
irradiation. Para-azidoblebbistatin inhibits Dd MD ATPase activity similarly to that of 
blebbistatin in the absence of UV irradiation. By a series of cross-linking cycles, we 
were able to saturate myosin in the presence of ADP by para-azidoblebbistatin. We 




• elimination of the salt bridge interactions between activation loop and actin N-
terminal region abolishes the activation of myosin’s ATPase activity, leaving 
other parameters of the enzymatic cycle intact, which demonstrates the specific 
role of activation loop in the actin activation of myosin  
• force-generation of muscles in vivo is regulated by actin activation of myosin 
through the interaction between activation loop and actin, tuning the efficiency 
of the actomyosin system 
• the interaction between activation loop and actin induces the extra primed state 
of myosin in the initial powerstroke actomyosin complex, the atomic structure of 
which has never been resolved before 
• the actin-binding region communicates with both the relay/converter structural 
domains and the nucleotide-binding pocket of myosin, which structural 
communication pathways are initiated by the formation of the interaction 
between activation loop and actin N-terminal region  
• structural knowledge of an intermediate state of the powerstroke i.e. resolving 
the atomic structure of the M.ADP.ABlebb state would lead us further in the 




The mechanistic model of parallel powerstroke pathways of myosin. Known and unknown 
structures of different states of the mechanistic model are showed by cartoon or schematic 
representations of the myosin motor domain (green) and actin (blue), respectively. Structural 
states resolved in this study or contributions to reveal a structure (initial powerstroke state, rigor 
and M.ADP.ABleb) are highlighted by grey background, as well as activation loop‒actin 
interaction revealed in this study, which enables the allosteric activation of myosin by actin. 
The widths of the arrows represent the relative fluxes of the pathways. The red, blue and orange 




• after the generation of activation loop mutations in Dictyostelium discoideum 
myosin II motor domain (Dd MD) by megaprimer PCR method and Mus 
musculus myosin Va S1 (myoV) by QuikChange mutagenezis, Dd MD 
constructs were expressed in Dictyostelium cell cultures while myoV constructs 
were produced in baculovirus‒Sf9 (Spodoptera frugiperda) expression system  
• protein purification was achieved by His- (Dd MD) and Flag-tagged (myoV) 
affinity chromatography 
• actin preparation was carried out from rabbit skeletal muscle, chemical 
modification was applied by labeling Cys374 of actin with pyrene (N-(1-
pyrene)iodoacetamide) 
• zero-length covalent cross-linking of Dd MD and actin was achieved by EDC (1-
ethyl-3-(3-dimethylaminopropyl) carbodiimide) 
• transient kinetic fluorescence measurements of Dd MD were performed by 
BioLogic SFM 300 stopped-flow, following intrinsic Trp (W501), mant-dADP 
(3'-(N-methylantraniloyl)-2'-deoxy–ADP) and pyrene-actin fluorescence changes 
on a transient time scale  
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• steady-state basal and actin activated ATPase activities of Dd MD and myoV 
was measured by a pyruvate kinase/lactate dehydrogenase coupled assay in a 
Schimadzu UV-2101 PC spectrophotometer 
• Dd MD‒actin steady-state co-sedimentation assay was carried out by 
ultracentrifugation, SDS-PAGE and densitometry of the gels 
• in vitro motility of TRITC-labeled (tetramethylrhodamine-5-isothiocyanate) 
actin filaments was visualized by Olympus IX71 
• transgenic Caenorhabditis elegans (C. elegans) strains were produced by 
microparticle bombardment 
• egg-production, lifespan and motility of C. elegans were quantified 
• atomic force microscopy (AFM) using AsylumResearch MFP3D was applied to 
measure force-generation of C. elegans  
• in silico preparation of protein structures was performed by Zhenhui Yang: 
  VO43- and BeF3- in 1VOM and 1MMD structures were replaced by Pi using 
Antechamber and Gaussian, missing residues of 1VOM, 2OVK and 1MMD 
were completed by homology modeling using Modeller 9.2, missing N-terminal 
region of actin was extended and capped with acetylate group (Acetyl-Asp1-Glu-
Asp-Glu4-actin) 
• actin-myosin docking was accomplished by Haddock V2.1 by Zhenhui Yang 
• molecular dynamic relaxation was carried out by Zhenhui Yang using Amber  
• chemical synthesis of para-azidoblebbistatin was performed by Miklós Képiró 
• covalent cross-linking of Dd MD and para-azidoblebbistatin was achieved by 
photoactivation of myosin-bound para-azidoblebbistatin 
• identification of para-azidoblebbistatin binding-peptides of myosin was achieved 
by mass spectrometry (by Miklós Képiró) and using Findmod program 
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